The University at Buffalo has received a prestigious recognition from the National Institutes of Health, a four-year $16 million Clinical Translational Science Award.
UB President Satish Tripathi says the grant recognizes the strong collaborations between UB and its partners on the Buffalo Niagara Medical Campus. He says Buffalo will soon become even more widely known.
"Major clinical trials will be conducted here. Research breakthroughs that change the face of modern medicine will take place here," said Tripathi in a news conference Thursday morning.
UB Vice President of Health Sciences Dr. Michael Cain says the award will profoundly expand the impact of Buffalo in driving clinical research and enhancing patient care.
"Patients in Western New York will have greater access to new treatments, health science students will have more opportunities for mentored research training, while new discoveries will draw private sector companies that create new jobs," Cain said.
Cain says the milestone is a Buffalo success story that would not have been possible without intense collaboration and teamwork among more than a dozen institutional and community partners. Those partners include Roswell Park Cancer Institute, the Great Lakes Health System and several local health organizations.